HeartBeam Q3 net loss narrows as operating expenses fall
BEAT•HeartBeam reported a third-quarter net loss of $3.01 million and operating expenses of $3.46 million. Operating cash outflow fell 23% from the prior quarter; the company expects full-year 2026 net operating cash outflow of $12.0 million to $12.5 million.
1. Quarterly results
HeartBeam reported a third-quarter net loss of $3.01 million, a loss of $0.05 per basic share, and income from operations of negative $3.46 million. Operating expenses were $3.46 million. The company said its net loss narrowed year over year as operating expenses declined.
2. Cash and strategy
Operating cash outflow fell 23% from the prior quarter, which the company attributed to cost-cutting measures, a reduced cost structure and lower headcount. HeartBeam expects fourth-quarter 2026 operating cash outflow below $2.5 million, barring accelerated study timing, and full-year 2026 net operating cash outflow of $12.0 million to $12.5 million. It expects its cash runway to extend further into 2027, aligned with achievement of key milestones. The company redirected most resources to heart attack assessment, citing a market opportunity four times larger than arrhythmia assessment.
